Machas & Partners successfully represented one of the country’s largest pharmaceutical companies in addressing a crisis related to the production and distribution of products in foreign markets that failed to meet established specifications and regulatory standards.
Our team supported the company by conducting an internal audit in collaboration with leading international technical consultants, designing and implementing the necessary corrective actions, and assisting with compliance under the oversight of supervisory authorities. These efforts were carried out in line with best practices to safeguard the company’s reputation, credibility, and business continuity.
